Dr. Maria Constanza Potilinski (Connie) was a visiting scholar in Dr. Ash’s lab working on Alpha-1-antitrypsin to delay retinal degeneration on a mice model of retinitis pigmentosa.
- Laboratory of Nano Medicine and Vision Group, Instituto de Investigaciones en Medicina Traslacional (IIMT), Buenos Aires, Postdoctoral Fellow
- National University of San Martin, Buenos Aires, Laboratory of Physiology and Biophysics, PhD in Molecular Biology and Biotechnology
Education & Training
New insights into oxidative stress and immune mechanisms involved in age-related macular degeneration tackled by novel therapies. Potilinski MC, Tate PS, Lorenc VE, Gallo JE. Neuropharmacology. 2021 May 1;188:108513. doi: 10.1016/j.neuropharm.2021.108513. Epub 2021 Mar 1.PMID: 33662390 Review.
Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach. Potilinski MC, Lorenc V, Perisset S, Gallo JE. Int J Mol Sci. 2020 Mar 28;21(7):2351. doi: 10.3390/ijms21072351.
Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy. Potilinski MC, Ortíz GA, Salica JP, López ES, Fernández Acquier M, Chuluyan E, Gallo JE. PLoS One. 2020 Feb 7;15(2):e0228895. doi: 10.1371/journal.pone.0228895. eCollection 2020.
Possible senescence associated change in the predominant a-Na+/K+ ATP-ase isoform in the renal cortex of the rat. Potilinski MC, Moretta R, Casal L, García Gras E, Amorena CE. Medicina (B Aires). 2016;76(4):204-7.